KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia

Thoraia Shinawi , Victoria Hill , Antonis Dagklis , Panagiotis Baliakas
Epigenetics 7 ( 3) 211 -215

27
2012
The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1.

P. J. Farrell , G. Niedobitek , A. Agathanggelou , L. Brooks
American Journal of Pathology 146 ( 5) 1102 -1112

14
1995
Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.

R. Tierney , A. Morgan , L. S. Young , E. L. Jones
American Journal of Pathology 145 ( 4) 969 -978

29
1994
1
2011
2.2 Controlled Depletion of Autologous T Cells Facilitates a Lasting CLL Proliferation in the CLL Xenograft Model

A. Skowronska , C. Odreive , A. Agathanggelou , G. Pratt
Clinical Lymphoma Myeloma and Leukemia 11 S160 -S161

2011
1.1 Inhibition of Deubiquitinating Enzyme USP7 Sensitizes CLL Tumor with ATM and p53 Dysfunction by Targeting Both Mdm2/p53 Loop and DNA Repair

A. Agathanggelou , N. Zlatanou , A. Gulshanara , G. Stewart
Clinical Lymphoma Myeloma and Leukemia 11 S141

2011
Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.

A. Agathanggelou , V. J. Weston , T. Perry , N. J. Davies
Haematologica 100 ( 8) 1076 -1085

10
2015
Identification of a single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene

S. Honorio , K. Gordon , D. MacCartney , A. Agathanggelou
Molecular and Cellular Probes 15 ( 6) 391 -393

2
2001
Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma.

M. Ilyas , G. Niedobitek , A. Agathanggelou , R. E. Barry
The Journal of Pathology 177 ( 2) 115 -122

38
1995
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice

C. E. Oldreive , A. Skowronska , N. J. Davies , H. Parry
Disease Models & Mechanisms 8 ( 11) 1401 -1412

3
2015
EPSTEIN–BARR VIRUS (EBV) INFECTION IN INFECTIOUS MONONUCLEOSIS: VIRUS LATENCY, REPLICATION AND PHENOTYPE OF EBV‐INFECTED CELLS

GERALD NIEDOBITEK , ANGELO AGATHANGGELOU , HERMANN HERBST , LUCIE WHITEHEAD
The Journal of Pathology 182 ( 2) 151 -159

201
1997
83
2003
Epigenetic Inactivation of the RASSF1A 3p21.3 Tumor Suppressor Gene in Both Clear Cell and Papillary Renal Cell Carcinoma

Catherine Morrissey , Alonso Martinez , Malgorzata Zatyka , Angelo Agathanggelou
Cancer Research 61 ( 19) 7277 -7281

173
2001
TLR9 expression in Chronic Lymphocytic Leukemia identifies a pro-migratory subpopulation and novel therapeutic target

Christopher Fegan , Ceri Oldreive , Timothy J Chevassut , Triantafillos Liloglou
Blood 137 ( 22) 3064 -3078

12
2021
BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia

Francesco Forconi , Andy Rawstron , Ceri Oldreive , Tatjana Stankovic
Blood 130 3004 -3004

2017
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

Angelo Agathanggelou , Sofia Honorio , Donia P Macartney , Alonso Martinez
Oncogene 20 ( 12) 1509 -1518

359
2001
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.

Dewi Astuti , Angelo Agathanggelou , Sofia Honorio , Ashraf Dallol
Oncogene 20 ( 51) 7573 -7577

120
2001
Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.

Sofia Honorio , Angelo Agathanggelou , Marcus Schuermann , Wulf Pankow
Oncogene 22 ( 1) 147 -150

101
2003